Journal of Reproductive Immunology
Volume 87, Issue 1 , Pages 67-73 , December 2010

The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth

  • Henriette Svarre Nielsen

      Affiliations

    • The Fertility Clinic, University Hospital Copenhagen, Rigshospitalet, Fertility Clinic 4071, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 35458486; fax: +45 35454946.
    • ,
  • Marian D. Witvliet

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Rudi Steffensen

      Affiliations

    • Department of Clinical Immunology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Geert W. Haasnoot

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Els Goulmy

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Ole Bjarne Christiansen

      Affiliations

    • The Fertility Clinic, University Hospital Copenhagen, Rigshospitalet, Fertility Clinic 4071, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • Department of Obstetrics and Gynaecology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark
    • ,
  • Frans Claas

      Affiliations

    • Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

Received 16 March 2010 ,Revised 21 May 2010 ,Accepted 23 May 2010.

References 

  1. Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal “self” hypothesis: a mechanism for maternal tolerance of the fetus. Placenta. 2007;28(5–6):378–382
  2. Ahrons S. HL-A antibodies: influence on the human foetus. Tissue Antigens. 1971;1(3):129–136
  3. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology. 2009;127(1):26–39
  4. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis 4. Transfusion. 2001;41(12):1524–1530
  5. Balasch J, Ercilla G, Vanrell JA, Vives J, Gonzalez-Merlo J. Effects of HLA antibodies on pregnancy. Obstet. Gynecol. 1981;57(4):444–446
  6. Beard RW, Braude P, Mowbray JF, Underwood JL. Protective antibodies and spontaneous abortion. Lancet. 1983;2(8358):p. 1090
  7. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum 1. Proc. Natl. Acad. Sci. U.S.A. 1996;93(2):705–708
  8. Christiansen OB, Nielsen HS, Kolte AM. Inflammation and miscarriage 5. Semin. Fetal Neonatal Med. 2006;11(5):302–308
  9. Christiansen OB, Pedersen B, Nielsen HS, Nybo Andersen AM. Impact of the sex of first child on the prognosis in secondary recurrent miscarriage. Hum. Reprod. 2004;19(12):2946–2951
  10. Gammill HS, Nelson JL. Naturally acquired microchimerism. Int. J. Dev. Biol. 2010;54(2-3):531–543
  11. Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast 10. Am. J. Obstet. Gynecol. 2006;195(1):29–39
  12. Johnson PM, Barnes RM, Hart CA, Francis WJ. Determinants of immunological responsiveness in recurrent spontaneous abortion. Transplantation. 1984;38(3):280–284
  13. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review 9. Arthritis Rheum. 2003;48(11):3237–3241
  14. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum. Reprod. Update. 2003;9(2):163–174
  15. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia 87. Clin. Chem. 2001;47(1):137–139
  16. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia 98. Clin. Chem. 1999;45(2):184–188
  17. McIntyre JA, McConnachie PR, Taylor CG, Faulk WP. Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertil. Steril. 1984;42(6):849–855
  18. Morales C, Sanchez A, Bruguera J, Margarit E, Borrell A, Borobio V, et al. Cytogenetic study of spontaneous abortions using semi-direct analysis of chorionic villi samples detects the broadest spectrum of chromosome abnormalities. Am. J. Med. Genet. A. 2008;146A(1):66–70
  19. Nielsen HS, Andersen AM, Kolte AM, Christiansen OB. A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study. Fertil. Steril. 2008;89(4):907–911
  20. Nielsen HS, Steffensen R, Lund M, Egestad L, Mortensen LH, Andersen AM, et al. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum. Reprod. 2010;25(6):1543–1552
  21. Nielsen HS, Steffensen R, Varming K, van Halteren AG, Spierings E, Ryder LP, et al. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum. Mol. Genet. 2009;18(9):1684–1691
  22. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil. Steril. 2000;73(2):300–304
  23. PAYNE R, ROLFS MR. Fetomaternal leukocyte incompatibility. J. Clin. Invest. 1958;37(12):1756–1763
  24. Power DA, Catto GR, Mason RJ, MacLeod AM, Stewart GM, Stewart KN, et al. The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigens. Lancet. 1983;2(8352):701–704
  25. Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important?. Obstet. Gynecol. 1993;82(1):132–138
  26. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601–611
  27. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum. Reprod. 1991;6(2):294–298
  28. Roelen DL, van BJ, Witvliet MD, Habraken I, van BE, van’t Sant PH, et al. IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not. Transplantation. 1994;57(9):1388–1392
  29. Sargent IL, Wilkins T, Redman CW. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet. 1988;2(8620):1099–1104
  30. Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, et al. Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin. Immunol. 2004;110(1):45–54
  31. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003;21:685–711
  32. Tongio MM, Berrebi A, Mayer S. A study of lymphocytotoxic antibodies in multiparous women having had at least four pregnancies. Tissue Antigens. 1972;2(5):378–388
  33. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, van BE, Roelen DL, Claas FH. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum. Immunol. 2001;62(3):201–207
  34. van Kampen CA, Versteeg-vd Voort Maarschalk MF, Langerak-Langerak J, Roelen DL, Claas FH. Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum. Immunol. 2002;63(6):452–458
  35. van Rood JJ, Eernisse JG, van LA. Leucocyte antibodies in sera from pregnant women. Nature. 1958;181(4625):1735–1736
  36. Verdijk RM, Kloosterman A, Pool J, van de KM, Naipal AM, van Halteren AG, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103(5):1961–1964
  37. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia 30. Ann. N. Y. Acad. Sci. 2001;945:138–140

PII: S0165-0378(10)00101-4

doi: 10.1016/j.jri.2010.05.006

Journal of Reproductive Immunology
Volume 87, Issue 1 , Pages 67-73 , December 2010

Article Tools